Northwestern Mutual Investment Management Company’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RRAM
FWIA
BTW
Northwestern Mutual Investment Management Company's HAE Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company increased its Haemonetics (HAE) stake by 0.41% in Q2 2026, buying an estimated $2.76K and bringing the position to 10,453 shares worth $784K. The position accounts for 0.01% of the portfolio, ranked #697.
Northwestern Mutual Investment Management Company first reported a position in HAE in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.07M in Q4 2020. 212 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Northwestern Mutual Investment Management Company held 10,453 shares of Haemonetics worth $784K as of Q2 2026.
- Northwestern Mutual Investment Management Company bought 43 Haemonetics shares in Q2 2026, an estimated $2.76K.
- Haemonetics made up 0.01% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #697 holding.
- Northwestern Mutual Investment Management Company first reported a position in Haemonetics in Q2 2018 and has held it in 33 quarters since.
- Northwestern Mutual Investment Management Company's Haemonetics position peaked at $2.07M in Q4 2020.
- 212 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.